Provincial Health Services Authority
People
Lead investigator
Distinguished scientist
Lead investigator
Renelle Myers
Lead investigator
Catherine Poh
Lead investigator
Sources: openalex.org, reporter.nih.gov
Trials
Low-dose Naltrexone for Post-COVID Fatigue Syndrome
Collaborator, Phase 2, Completed, 160 people, Jun 24, 2022
Collaborator, Phase 4, Withdrawn, 0 people, Jun 20, 2008
Sources: clinicaltrials.gov
Grants and prizes
Breast Cancer Research Foundation
Developing predictive biomarkers for genome targeting agents in TNBC, to single cell resolution, BCRF-26-180, 225K, 2026–2027, Oct 1, 2026
U01, Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions, U01CA253858, $1.6M, 2022–2027, Sep 8, 2025
Canadian Cancer Society Research Institute
CCS/CIHR/BC Spark Grants, Long read DNA methylation sequencing for early detection of pancreatic adenocarcinoma, CCS-2021-ccs-cihr-bc-spark-grants-marra-marco, CA$150K, 2021, Jan 1, 2021
Canadian Cancer Society Research Institute
CCS/CIHR/BC Spark Grants, Early detection of lung cancer using VOC from breath and sweat, CCS-2021-ccs-cihr-bc-spark-grants-myers-renelle, CA$150K, 2021, Jan 1, 2021
Canadian Cancer Society Research Institute
CCS/CIHR/BC Spark Grants, Cytology-based DNA measurement for oral cancer screening, CCS-2021-ccs-cihr-bc-spark-grants-poh-catherine, CA$150K, 2021, Jan 1, 2021
Sources: openalex.org, reporter.nih.gov
Funded papers
May 1, 2024
Sources: openalex.org
Named in competing interests
Chronic kidney disease, complex conditions, and advancing therapeutics: new hope and challenges
Grants or research support, Jun 3, 2026
Sources: pubmed.ncbi.nlm.nih.gov
Papers
Journal of multimorbidity and comorbidity, Aug 22, 2026
A systematic review and meta-analysis of disease clusters in multimorbidity
Nature communications, Dec 27, 2025
Cities (London, England), Sep 17, 2025
Systematic review and meta-analysis of disease clustering in multimorbidity: a study protocol
BMJ open, Dec 10, 2023
Injury epidemiology, Oct 18, 2016